Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Preferred Stock Liabilities (2020 - 2021)

Core Scientific (CORZW) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $44.5 million as the latest value for Q4 2021.

  • Quarterly Preferred Stock Liabilities changed 0.0% to $44.5 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $44.5 million through Dec 2021, changed 0.0% year-over-year, with the annual reading at $44.5 million for FY2021, 0.0% changed from the prior year.
  • Preferred Stock Liabilities hit $44.5 million in Q4 2021 for Core Scientific, down from $345.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $345.0 million in Q3 2021 to a low of $44.5 million in Q4 2020.